Jiang Hai-Shan, Wang Dong-Mei, Wang Qun, Yang Man, Wang Wei, Pan Su-Yue, Hu Ya-Fang
Department of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.E-mail:
Nan Fang Yi Ke Da Xue Xue Bao. 2016 Jun 20;36(7):883-6.
Mutations in CACNA1A, which encodes the P/Q-type calcium channel subunit, are responsible for at least 3 allelic diseases, namely type 2 episodic ataxia (EA-2), familial hemiplegic migraine?type-1 (FHM1), and spinocerebellar ataxia type-6?(SCA 6). Herein we present a case of ataxia with episodic tremors in a 19-year-old man with a missense mutation of CACNA1A gene and summarize the clinical features, genetic analysis and treatment in this case and in his affected family members.
Physical examinations were conducted for the patient and his affected family members. DNA sample from the proband was analyzed with next-generation sequencing technology to identify the causative mutation. Sanger sequencing was used to confirm the gene mutation in the family members.
Physical examinations of the patient revealed signs of ataxia, drunken gait, and tremor of his head and body. Four other members in his family had similar but much milder symptoms. A heterozygous missense mutation in CACNA1A (NM_001127221.1 c.4034G->A, p.R1345Q, exon 25) was identified in the proband, which was confirmed in the affected family members. The proband did not respond to methazolamide treatment, but his tremor symptom was well controlled with flunarizine, a calcium channel blocker.
Based on the clinical features, mutation analysis and treatment response, we suggest that this patient with a missense CACNA1A mutation, R1345Q, has a new type of ataxia with episodic tremor other than any of EA2, FHM1, or SCA 6.
编码P/Q型钙通道亚基的CACNA1A基因突变至少导致3种等位基因疾病,即2型发作性共济失调(EA - 2)、1型家族性偏瘫性偏头痛(FHM1)和6型脊髓小脑共济失调(SCA 6)。在此,我们报告1例19岁男性携带CACNA1A基因错义突变,伴有发作性震颤的共济失调病例,并总结该病例及其患病家庭成员的临床特征、基因分析和治疗情况。
对患者及其患病家庭成员进行体格检查。采用下一代测序技术分析先证者的DNA样本以确定致病突变。使用桑格测序法确认家庭成员中的基因突变。
患者体格检查发现共济失调体征、醉酒步态以及头部和身体震颤。其家族中的其他4名成员有类似但症状较轻的表现。在先证者中鉴定出CACNA1A基因的杂合错义突变(NM_001127221.1 c.4034G→A,p.R1345Q,第25外显子),患病家庭成员中也得到证实。先证者对乙酰唑胺治疗无反应,但他的震颤症状通过钙通道阻滞剂氟桂利嗪得到了很好的控制。
基于临床特征、突变分析和治疗反应,我们认为该携带错义CACNA1A突变R1345Q的患者患有除EA2、FHM1或SCA 6之外的一种新型伴有发作性震颤的共济失调。